-
Avacta Appoints Brian Hahn as Chief Financial Officer
13 Jan 2025 12:00 GMT
… Executive Director of Finance at MiddleBrook Pharmaceuticals (formerly Advancis Pharmaceutical), and earlier … -specific release mechanism, providing unique benefits over traditional antibody drug conjugates.
-
The Economic Prescription: Unpacking the 2023 Recession's Penicillin Market Effects
03 Oct 2023 09:43 GMT
… LAMEA)
Competitive Landscape:
GlaxoSmithKline plc.
MiddleBrook Pharmaceuticals, Inc., F.
Hoffmann-La Roche … -for-customization/4665
KEY BENEFITS FOR STAKEHOLDERS:
This report offers …
-
Maxwell Biosciences Expands Leadership Team with the Appointment of Three Senior Executives
20 Sep 2022 12:36 GMT
… to more rapidly realize the benefits of our platform, offering a … viruses, bacteria and fungi to benefit patients across a variety of … Development and Manufacturing Operations at MiddleBrook Pharmaceuticals, Inc. (formerly Advancis Corporation), and …
-
Maxwell Biosciences Announces the Appointment of Edward Rudnic, Ph.D., as Chief Operating Officer
21 Apr 2022 12:32 GMT
… founder, chairman, and CEO of MiddleBrook Pharmaceuticals, where he raised $300M in … platform with the potential to benefit so many lives,” says Dr …